FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for Losartan Potassium Tablets, 25 mg, under ANDA201170.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Losartan Potassium Tablets, 25 mg (LOSARTAN POTASSIUM)

Snippet

SUPPL AP for LOSARTAN POTASSIUM TABLETS, 25 MG (LOSARTAN POTASSIUM)